The FDA has approved a firmware update aimed at addressing two previously reported issues with some of Abbott’s implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
A regular intake of up to 300 mg of coffee a day appears to be safe and may even be protective against heart rhythm disorders, including atrial fibrillation (AFib), according to a new review published April 16 in the Journal of the American College of Cardiology.
Only half of medical advice on an online message board dedicated to implanted cardiac defibrillators (ICDs) appears to be accurate, according to preliminary research presented April 7 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018.
Atrial fibrillation (AFib) ablation techniques used on individuals without cardiac abnormalities can be safely applied to adults with congenital heart disease (CHD), according to a new study in JACC: Clinical Electrophysiology. But in many cases, multiple ablation procedures are needed to boost the chances of arrhythmia-free survival.
A 6-month-old German Shepherd was the beneficiary of a successful cardiac ablation at Cornell University Hospital for Animals, one of only two centers in the U.S. that regularly offers the procedure for dogs.
Patients who developed new-onset postoperative atrial fibrillation (POAF) after coronary artery bypass graft (CABG) surgery showed a 33 percent reduced risk of thromboembolism long-term when compared to those with nonsurgical AFib, according to a study published March 28 in JAMA Cardiology.
New research presented at the American Heart Association’s Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2018 suggests individuals with depression may have an increased risk of developing atrial fibrillation (AFib).
Current clinical guidelines recommend implantable cardioverter-defibrillators (ICDs) in survivors of sudden cardiac arrest (SCA), except when the cause of the SCA is deemed reversible. But a new study in Circulation: Arrhythmia and Electrophysiology demonstrates that many of these patients gain a survival benefit from ICDs as well.
Continuous anticoagulation with apixaban during atrial fibrillation (AFib) ablation was found to be as safe as warfarin and other vitamin K antagonists (VKAs) in a randomized trial of 633 patients.
Higher alcohol consumption was linked to faster and faster heart rates in a study of more than 3,000 people attending the Munich Oktoberfest.
A chest patch that records heartbeat patterns could potentially be a better detector of atrial fibrillation (AFib) and subsequently can expedite more timely treatment than traditional treatment, according to new research presented at the American College of Cardiology's 67th Annual Scientific Session.
The VEST study—an effort to reduce post-myocardial infarction (MI) mortality and one of ACC 18’s most anticipated clinical trials—failed to meet its primary endpoint of reducing sudden death due to ventricular arrhythmias, study leader Jeffrey Olgin, MD, announced to a crowd of thousands following ACC’s opening ceremony Saturday.
The FDA announced on Feb. 26 a Class I recall for nine of Medtronic's cardiac resynchronization therapy with defibrillation (CRT-D) devices and 12 of its implantable cardioverter-defibrillators (ICDs). Due to a manufacturing defect, a gas mixture can enter the devices and hamper their ability to provide shock therapy.
The American Heart Association (AHA) believes an additional 50,000 lives per year could be saved if all hospitals in the United States adopted its Resuscitation Quality Improvement (RQI) program.
The clinical benefit patients gain from remote monitoring with implantable electronic devices far outweighs the risk of the devices being hacked, according to a paper published Feb. 20 by the American College of Cardiology’s Electrophysiology Council.
The FDA has approved a firmware update aimed at addressing two previously reported issues with some of Abbott’s implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds).
A regular intake of up to 300 mg of coffee a day appears to be safe and may even be protective against heart rhythm disorders, including atrial fibrillation (AFib), according to a new review published April 16 in the Journal of the American College of Cardiology.
Only half of medical advice on an online message board dedicated to implanted cardiac defibrillators (ICDs) appears to be accurate, according to preliminary research presented April 7 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018.
Atrial fibrillation (AFib) ablation techniques used on individuals without cardiac abnormalities can be safely applied to adults with congenital heart disease (CHD), according to a new study in JACC: Clinical Electrophysiology. But in many cases, multiple ablation procedures are needed to boost the chances of arrhythmia-free survival.
A 6-month-old German Shepherd was the beneficiary of a successful cardiac ablation at Cornell University Hospital for Animals, one of only two centers in the U.S. that regularly offers the procedure for dogs.
Patients who developed new-onset postoperative atrial fibrillation (POAF) after coronary artery bypass graft (CABG) surgery showed a 33 percent reduced risk of thromboembolism long-term when compared to those with nonsurgical AFib, according to a study published March 28 in JAMA Cardiology.